AmpliPhi's Bacteriophage Work Boosted in Merger
By Nuala Moran
Wednesday, November 21, 2012
LONDON There may not be that much competition, but AmpliPhi Biosciences Corp. now claims to be the world's leading bacteriophage company, following completion of its merger with Sydney, Australia-based Special Phage Services Pty.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.